SCHEMBL2646435

SCHEMBL2646435

CC(=O)Nc1cccc(-c2cncnc2)c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 1/20 0.63
CNR2 P34972 1/20 0.63
PIP4K2A P48426 1/20 0.60
PIP4K2B P78356 1/20 0.60
FYN P06241 4/20 0.58
CYP17A1 P05093 3/20 0.58
CYP11B1 P15538 1/20 0.58
CYP11B2 P19099 1/20 0.58
BRAF P15056 2/20 0.56
NQO2 P16083 2/20 0.55
NPC1 O15118 2/20 0.55
RAB9A P51151 2/20 0.55
SMN1; SMN2 Q16637 2/20 0.55
TSHR P16473 1/20 0.55
TP53 P04637 1/20 0.55
STAT1 P42224 1/20 0.55
MAP4K4 O95819 1/20 0.54
MAPT P10636 1/20 0.54
HSD17B1 P14061 1/20 0.54
HSD17B2 P37059 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11222723 0.86 CNR1 (0.64) CNR1PIP4K2APIP4K2BFYNCYP17A1
SCHEMBL2183682 0.83 CYP3A4 (0.62) CNR1CNR2NPC1RAB9ASMN1; SMN2
SCHEMBL10663620 0.82 CYP17A1 (0.76) CNR1PIP4K2APIP4K2BFYNCYP17A1
SCHEMBL4189391 0.82 PIP4K2A (0.62) PIP4K2APIP4K2BFYNCYP17A1CYP11B1
SCHEMBL3786463 0.81 NQO2 (0.73) CNR1CYP17A1CYP11B1CYP11B2NQO2
SCHEMBL4191864 0.81 BRAF (0.70) PIP4K2APIP4K2BFYNCYP17A1CYP11B1
SCHEMBL8577619 0.80 SMN1; SMN2 (0.70) CNR1PIP4K2APIP4K2BCYP17A1CYP11B1
SCHEMBL30339454 0.80 SMN1; SMN2 (0.70) PIP4K2APIP4K2BCYP17A1NPC1RAB9A
SCHEMBL2648798 0.79 FYN (0.54) PIP4K2APIP4K2BFYNCYP17A1CYP11B1
SCHEMBL17742694 0.78 MKNK2 (0.55) CNR1CNR2FYNMAP4K4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007130743-A2 CAPREOMYCIN DERIVATIVES AND THEIR USE AS ANTIBACTERIALS ARRAY BIOPHARMA, INC. (US) 2007-11-15 WO disclosed
EP-0821683-B1 BENZIMIDAZOLE COMPOUNDS AND THEIR USE AS MODULATORS OF THE GABA A RECEPTOR COMPLEX NEUROSEARCH AS (DK) 2006-11-02 EP disclosed
US-5902813-A MODULATORS OF THE BENZODIAXEPINE RECEPTOR OT THE GAMMA-BUTYRIC ACID(A) RECEPTOR COMPLEX; ANXIOLYTIC, ANTIEPILEPTIC AND -CONVULSANT AGENTS; SLEEP AND MEMORY DISORDERS NEUROSEARCH A/S (DK) 1999-05-11 US disclosed
EP-0821683-A1 BENZIMIDAZOLE COMPOUNDS AND THEIR USE AS MODULATORS OF THE GABA A? RECEPTOR COMPLEX NEUROSEARCH A/S (DK) 1998-02-04 EP disclosed
WO-1996033192-A1 BENZIMIDAZOLE COMPOUNDS AND THEIR USE AS MODULATORS OF THE GABAA RECEPTOR COMPLEX NEUROSEARCH A/S (DK) 1996-10-24 WO disclosed